Overview

• The company plans to use the funding to scale product development, expand its engineering team, and speed enterprise adoption of its platform.
• Graph Safety automates case processing, signal detection, and regulatory reporting using context-aware AI while preserving human review for critical steps.
• Graph AI says it has deployed with enterprise customers and is building a pipeline spanning more than 7,000 marketed drugs.
• Customer-reported results include up to 70% efficiency gains and 90% faster regulatory reporting with full traceability and audit readiness.
• Bessemer’s Nithin Kaimal described the bet as shifting the $8 billion pharmacovigilance market from manual outsourcing to AI-driven systems.